In a positive feedback loop, the KMT2A-AF4 fusion protein activates a single member of the SEC, the P-TEFb kinase, which triggers the activity of promoter-arrested RNA polymerase II, and ultimately alters the pattern of the ALL transcriptional profile [38]. Here, KMT2A is linked to acute lymphoblastic leukemia.